» Articles » PMID: 36917461

Association of Accompanying Dyspnoea with Diagnosis and Outcome of Patients Presenting with Acute Chest Discomfort

Abstract

Aims: The presence of accompanying dyspnoea is routinely assessed and common in patients presenting with acute chest pain/discomfort to the emergency department (ED). We aimed to assess the association of accompanying dyspnoea with differential diagnoses, diagnostic work-up, and outcome.

Methods And Results: We enrolled patients presenting to the ED with chest pain/discomfort. Final diagnoses were adjudicated by independent cardiologists using all information including cardiac imaging. The primary diagnostic endpoint was the final diagnosis. The secondary diagnostic endpoint was the performance of high-sensitivity cardiac troponin (hs-cTn) and the European Society of Cardiology (ESC) 0/1h-algorithms for the diagnosis of myocardial infarction (MI). The prognostic endpoints were cardiovascular and all-cause mortality at two years. Among 6045 patients, 2892/6045 (48%) had accompanying dyspnoea. The prevalence of acute coronary syndrome (ACS) in patients with vs. without dyspnoea was comparable (MI 22.4% vs. 21.9%, P = 0.60, unstable angina 8.7% vs. 7.9%, P = 0.29). In contrast, patients with dyspnoea more often had cardiac, non-coronary disease (15.3% vs. 10.2%, P < 0.001). Diagnostic accuracy of hs-cTnT/I concentrations was not affected by the presence of dyspnoea (area under the curve 0.89-0.91 in both groups), and the safety of the ESC 0/1h-algorithms was maintained with negative predictive values >99.4%. Accompanying dyspnoea was an independent predictor for cardiovascular and all-cause death at two years [hazard ratio 1.813 (95% confidence intervals, 1.453-2.261, P < 0.01)].

Conclusion: Accompanying dyspnoea was not associated with a higher prevalence of ACS but with cardiac, non-coronary disease. While the safety of the diagnostic work-up was not affected, accompanying dyspnoea was an independent predictor for cardiovascular and all-cause death.

Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT00470587, number NCT00470587.

References
1.
Lopez-Ayala P, Nestelberger T, Boeddinghaus J, Koechlin L, Ratmann P, Strebel I . Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm. Circulation. 2021; 144(10):773-787. DOI: 10.1161/CIRCULATIONAHA.120.052982. View

2.
Miller-Hodges E, Anand A, Shah A, Chapman A, Gallacher P, Lee K . High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome. Circulation. 2017; 137(5):425-435. PMC: 5793996. DOI: 10.1161/CIRCULATIONAHA.117.030320. View

3.
Boeddinghaus J, Nestelberger T, Koechlin L, Wussler D, Lopez-Ayala P, Walter J . Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I. J Am Coll Cardiol. 2020; 75(10):1111-1124. DOI: 10.1016/j.jacc.2019.12.065. View

4.
Botker M, Stengaard C, Stromgaard Andersen M, Sondergaard H, Dodt K, Niemann T . Dyspnea, a high-risk symptom in patients suspected of myocardial infarction in the ambulance? A population-based follow-up study. Scand J Trauma Resusc Emerg Med. 2016; 24:15. PMC: 4751637. DOI: 10.1186/s13049-016-0204-9. View

5.
Gimenez M, Twerenbold R, Jaeger C, Schindler C, Puelacher C, Wildi K . One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. 2015; 128(8):861-870.e4. DOI: 10.1016/j.amjmed.2015.01.046. View